Northern New Jersey CCOP — Hackensack, New Jersey

Northern New Jersey CCOP is a clinical research site located in Hackensack, New Jersey, United States 07601.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Northern New Jersey CCOP has participated in 2 clinical trials.

Therapeutic areas: Breast Cancer, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma.

Sponsors: Stanford University, National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Northern New Jersey CCOP?

Northern New Jersey CCOP has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Northern New Jersey CCOP conducted?

Northern New Jersey CCOP has 2 clinical trials on record. Their work covers Breast Cancer, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma.

Is Northern New Jersey CCOP accredited by Crixeo Health?

Northern New Jersey CCOP has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Northern New Jersey CCOP?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.